{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:41:32Z","timestamp":1707921692642},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11906-006-0082-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:46:50Z","timestamp":1180054010000},"page":"384-390","source":"Crossref","is-referenced-by-count":3,"title":["Expanding the definition of hypertension to incorporate global cardiovascular risk"],"prefix":"10.1007","volume":"8","author":[{"given":"Nitin","family":"Khosla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry R.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"82_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1524-6175.2006.04895.x","volume":"8","author":"BM Cheung","year":"2006","unstructured":"Cheung BM, Ong KL, Man YB, et al.: Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001\u20132002. J Clin Hypertens (Greenwich) 2006, 8:93\u201398.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560\u20132572. This reference provides the most comprehensive guide of how to treat patients with hypertension.","journal-title":"JAMA"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903\u20131913.","journal-title":"Lancet"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.1991.03460040065031","volume":"265","author":"L Farnett","year":"1991","unstructured":"Farnett L, Mulrow CD, Linn WD, et al.: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991, 265:489\u2013495.","journal-title":"JAMA"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ajh\/2.10.816","volume":"2","author":"NM Kaplan","year":"1989","unstructured":"Kaplan NM: Critical comments on recent literature. The J curve and other problems with therapy. Am J Hypertens 1989, 2:132\u2013133.","journal-title":"Am J Hypertens"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.amjcard.2004.08.010","volume":"95","author":"FH Messerli","year":"2005","unstructured":"Messerli FH, Kupfer S, Pepine CJ: J curve in hypertension and coronary artery disease. Am J Cardiol 2005, 95:160.","journal-title":"Am J Cardiol"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755\u20131762.","journal-title":"Lancet"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"ZD de","year":"2004","unstructured":"de ZD, Remuzzi G, Parving HH, et al.: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110:921\u2013927.","journal-title":"Circulation"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.2004090763","volume":"16","author":"T Berl","year":"2005","unstructured":"Berl T, Hunsicker LG, Lewis JB, et al.: Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 2005, 16:2170\u20132179.","journal-title":"J Am Soc Nephrol"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)12475-0","volume":"361","author":"R Collins","year":"2003","unstructured":"Collins R, Armitage J, Parish S, et al.: MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003, 361:2005\u20132016.","journal-title":"Lancet"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495\u20131504.","journal-title":"N Engl J Med"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD, et al.: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005, 352:1425\u20131435.","journal-title":"N Engl J Med"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.0000066320.27195.B4","volume":"107","author":"ES Ford","year":"2003","unstructured":"Ford ES, Mokdad AH, Giles WH, Mensah GA: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003, 107:2185\u20132189.","journal-title":"Circulation"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/archinte.164.19.2119","volume":"164","author":"LB Russell","year":"2004","unstructured":"Russell LB, Valiyeva E, Carson JL: Effects of prehypertension on admissions and deaths: a simulation. Arch Intern Med 2004, 164:2119\u20132124.","journal-title":"Arch Intern Med"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1370\/afm.312","volume":"3","author":"HA Liszka","year":"2005","unstructured":"Liszka HA, Mainous AG III, King DE, et al.: Prehypertension and cardiovascular morbidity. Ann Fam Med 2005, 3:294\u2013299.","journal-title":"Ann Fam Med"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjmed.2005.08.023","volume":"119","author":"AV Kshirsagar","year":"2006","unstructured":"Kshirsagar AV, Carpenter M, Bang H, et al.: Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006, 119:133\u2013141.","journal-title":"Am J Med"},{"key":"82_CR17","doi-asserted-by":"crossref","unstructured":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997, 157:657\u2013667.","DOI":"10.1001\/archinte.157.6.657"},{"key":"82_CR18","doi-asserted-by":"crossref","unstructured":"The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med 1991, 151:1413\u20131423.","DOI":"10.1001\/archinte.1991.00400070161023"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa060838","volume":"354","author":"S Julius","year":"2006","unstructured":"Julius S, Nesbitt SD, Egan BM, et al.: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006, 354:1685\u20131697.","journal-title":"N Engl J Med"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-144-7-200604040-00007","volume":"144","author":"PJ Elmer","year":"2006","unstructured":"Elmer PJ, Obarzanek E, Vollmer WM, et al.: Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006, 144:485\u2013495.","journal-title":"Ann Intern Med"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","volume":"134","author":"VJ Stevens","year":"2001","unstructured":"Stevens VJ, Obarzanek E, Cook NR, et al.: Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001, 134:1\u201311.","journal-title":"Ann Intern Med"},{"issue":"Suppl3","key":"82_CR22","first-page":"S51","volume":"24","author":"EL Schiffrin","year":"1994","unstructured":"Schiffrin EL, Deng LY, Larochelle P: Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients. J Cardiovasc Pharmacol 1994, 24(Suppl3):S51-S56.","journal-title":"J Cardiovasc Pharmacol"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00004872-199816010-00013","volume":"16","author":"A Rudnichi","year":"1998","unstructured":"Rudnichi A, Safar M, Asmar R, et al.: Prevalence of cardiovascular risk factors in a French population. J Hypertens Suppl 1998, 16:S85-S90.","journal-title":"J Hypertens Suppl"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/diacare.15.9.1181","volume":"15","author":"T Deckert","year":"1992","unstructured":"Deckert T, Kofoed-Enevoldsen A, Norgaard K, et al.: Microalbuminuria. Implications for micro-and macrovascular disease. Diabetes Care 1992, 15:1181\u20131191.","journal-title":"Diabetes Care"},{"key":"82_CR25","first-page":"285","volume":"54","author":"P Gosling","year":"1995","unstructured":"Gosling P: Microalbuminuria: a marker of systemic disease. Br J Hosp Med 1995, 54:285\u2013290.","journal-title":"Br J Hosp Med"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(96)00272-6","volume":"34","author":"CD Stehouwer","year":"1997","unstructured":"Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997, 34:55\u201368.","journal-title":"Cardiovasc Res"},{"key":"82_CR27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.164.12.1313","volume":"164","author":"JG O\u2019Meara","year":"2004","unstructured":"O\u2019Meara JG, Kardia SL, Armon JJ, et al.: Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004, 164:1313\u20131318.","journal-title":"Arch Intern Med"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.159.10.1104","volume":"159","author":"PW Wilson","year":"1999","unstructured":"Wilson PW, Kannel WB, Silbershatz H, D\u2019Agostino RB: Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999, 159:1104\u20131109.","journal-title":"Arch Intern Med"},{"key":"82_CR29","first-page":"3085","volume":"85","author":"T McLaughlin","year":"2000","unstructured":"McLaughlin T, Abbasi F, Lamendola C, et al.: Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. J Clin Endocrinol Metab 2000, 85:3085\u20133088.","journal-title":"J Clin Endocrinol Metab"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","volume":"28","author":"R Kahn","year":"2005","unstructured":"Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289\u20132304.","journal-title":"Diabetes Care"},{"key":"82_CR31","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735\u20132752.","journal-title":"Circulation"},{"key":"82_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2005.11.046","volume":"47","author":"SM Grundy","year":"2006","unstructured":"Grundy SM: Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006, 47:1093\u20131100.","journal-title":"J Am Coll Cardiol"},{"key":"82_CR33","doi-asserted-by":"crossref","unstructured":"Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"82_CR34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","volume":"24","author":"B Isomaa","year":"2001","unstructured":"Isomaa B, Almgren P, Tuomi T, et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683\u2013689.","journal-title":"Diabetes Care"},{"key":"82_CR35","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","volume":"24","author":"BG De","year":"2003","unstructured":"De BG, Ambrosioni E, Borch-Johnsen K, et al.: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003, 24:1601\u20131610.","journal-title":"Eur Heart J"},{"key":"82_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.mlr.0000188982.25397.37","volume":"44","author":"ML Johnson","year":"2006","unstructured":"Johnson ML, Pietz K, Battleman DS, Beyth RJ: Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care 2006, 44:39\u201346.","journal-title":"Med Care"},{"key":"82_CR37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335\u2013342.","journal-title":"JAMA"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003, 326:1427.","journal-title":"BMJ"},{"key":"82_CR39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0895-7061(01)02167-7","volume":"14","author":"MR Weir","year":"2001","unstructured":"Weir MR, Rosenberger C, Fink JC: Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens 2001, 14:963\u2013968.","journal-title":"Am J Hypertens"},{"key":"82_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9343(01)00799-9","volume":"111","author":"TC Andrews","year":"2001","unstructured":"Andrews TC, Ballantyne CM, Hsia JA, Kramer JH: Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Am J Med 2001, 111:185\u2013191.","journal-title":"Am J Med"},{"key":"82_CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9149(01)02337-2","volume":"89","author":"DG Karalis","year":"2002","unstructured":"Karalis DG, Ross AM, Vacari RM, et al.: Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease. Am J Cardiol 2002, 89:667\u2013671.","journal-title":"Am J Cardiol"},{"key":"82_CR42","first-page":"e85","volume":"113","author":"T Thom","year":"2006","unstructured":"Thom T, Haase N, Rosamond W, et al.: Heart disease and stroke statistics\u20142006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151.","journal-title":"Circulation"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0082-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-006-0082-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0082-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:09:29Z","timestamp":1707919769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-006-0082-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11906-006-0082-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}